<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Heparin Sodium | Norepinephrine  by Shantal Marie Medrozo</title>
      <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v</link>
      <description>Drug study</description>
      <language>en-us</language>
      <pubDate>2021-09-13 11:42:04 UTC</pubDate>
      <lastBuildDate>2023-03-03 04:35:34 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735768031</link>
         <description><![CDATA[<div>Generic name: Heparin<br>Brand name: Hepalean (CAN)</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1297659218/db62b50de14090b67cb8ab8680983fae/heparin_sodium.jpeg" />
         <pubDate>2021-09-13 11:48:50 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735768031</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735776251</link>
         <description><![CDATA[<div>Dosages : </div><div>ADULTS<br>- <em>Subcutaneous (deep subcutaneous injection)</em></div><ul><li>For general anticoagulation: IV loading dose of 5,000 units and then 10,000–20,000 units subcutaneously followed by 8,000–10,000 units q 8 hr or 15,000–20,000 units q 12 hr.</li></ul><div>IV</div><ul><li>Intermittent IV: Initial dose of 10,000 units and then 5,000–10,000 units q 4–6 hr.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:53:01 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735776251</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735779341</link>
         <description><![CDATA[<div><strong>Classification&nbsp;</strong></div><ul><li>Anticoagulants , Cardiovascular</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:54:43 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735779341</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735780873</link>
         <description><![CDATA[<div><strong>Mechanism of Action&nbsp;</strong></div><ul><li>It produces its major anticoagulant effect by inactivating thrombin and activated factor X (factor Xa) through an antithrombin (AT)-dependent mechanism.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:55:22 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735780873</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735782562</link>
         <description><![CDATA[<div><strong>Indication/s&nbsp;</strong></div><div>​​Heparin sodium is used to treat the following conditions:</div><ul><li>Treatment of consumptive coagulopathies (disseminated intravascular coagulation) in both acute and chronic forms.</li><li>Thrombosis prevention in vascular and cardiac surgery</li><li>Anticoagulant usage in blood transfusions, extracorporeal circulation, and dialysis treatments; prevention and treatment of peripheral artery embolism.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:56:12 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735782562</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735783684</link>
         <description><![CDATA[<div><strong>Contraindications</strong></div><ul><li>Patients with hypersensitivity to the drug, past or present heparin-induced thrombocytopenia and active bleeding.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:56:47 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735783684</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735784550</link>
         <description><![CDATA[<div><strong>&nbsp;Side Effects and Adverse Effects</strong>&nbsp;</div><ul><li>Easy bleeding and bruising</li><li>Discomfort, redness, warmth, irritation, or skin changes where the drug was injected</li><li>Itching of your feet; or bluish-colored skin are all common Heparin side effects.</li><li>Heparin's adverse effects include thrombocytopenia, heparin-induced thrombocytopenia (HIT), and heparin-induced thrombocytopenia and thrombosis (HITT).</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:57:15 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735784550</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735786510</link>
         <description><![CDATA[<div><strong>Nursing Responsibilities</strong></div><ul><li>Always check compatibilities with other IV solutions.</li><li>Give deep subcutaneous injections; do not give heparin by IM injection.</li><li>Check for signs of bleeding; monitor blood tests.</li><li>Alert all health care providers of heparin use.</li><li>Have protamine sulfate (heparin antidote) readily available in case of overdose; each mg neutralizes 100 units of heparin.</li><li>Report nose bleed, bleeding of the gums, unusual bruising, black or tarry stools, cloudy or dark urine, abdominal or lower back pain, severe headache.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 11:58:14 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735786510</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735824984</link>
         <description><![CDATA[<div>Generic name: Norepinephrine Hydrochloride<br>Brand name: Levophed; Norepin</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1297659218/2403b04504f1ab4f87c0101f542fc082/nire.webp" />
         <pubDate>2021-09-13 12:16:13 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735824984</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735827141</link>
         <description><![CDATA[<div><strong>Stock Dosage&nbsp;</strong></div><div>Initial: 8-12 mcg/min IV infusion; titrate to effect<br>Maintenance: 2-4 mcg/min IV infusion</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:17:07 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735827141</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735828394</link>
         <description><![CDATA[<div><strong>&nbsp;Classification&nbsp;</strong></div><ul><li>Alpha/Beta Adrenergic Agonists</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:17:41 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735828394</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735830221</link>
         <description><![CDATA[<div><strong>Indication/s&nbsp;</strong></div><ul><li>Mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock and has shown a survival benefit over dopamine. Also used as a vasopressor medication for patients with critical hypotension.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:18:10 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735830221</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735832008</link>
         <description><![CDATA[<div><strong>Contraindications</strong></div><ul><li>Patients that are hypersensitivity to the drug; Low blood pressure (hypotension) due to blood volume deficit and has Peripheral vascular thrombosis</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:18:54 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735832008</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735833846</link>
         <description><![CDATA[<div><strong>Side Effects and Adverse Effects</strong>&nbsp;</div><ul><li>Slow heart rate, High blood pressure (hypertension), Irregular heartbeats (arrhythmias), Confusion, Anxiety, Shortness of breath, with or without respiratory difficulty, Headache, Nausea and vomiting</li><li>Potentially Fatal: Pain or burning where the injection is given, Sudden numbness/weakness/cold feeling in your body, Blue lips or fingernails</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:19:36 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735833846</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735835764</link>
         <description><![CDATA[<div><strong>&nbsp;Nursing Responsibilities</strong></div><ul><li>Monitor blood pressure and apical pulse continously during norepinephrine therapy.</li><li>Cardiac monitor should be used on patients receiving norepinephrine IV infusions.</li><li>Defibrillator and resuscitation cart should be close by during infusion.</li><li>Titrate infusion rate to maintain systolic BP at 80 – 100 mg Hg.</li><li>Assess patient frequently for headache, chest pain, or other signs of toxicity.</li><li>Do not mix other medications in IV line with norepinephrine drip.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:20:22 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735835764</guid>
      </item>
      <item>
         <title></title>
         <author>medrozoshantalmarie</author>
         <link>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735839263</link>
         <description><![CDATA[<div><strong>&nbsp;Mechanism of Action&nbsp;</strong></div><ul><li>Norepinephrine functions as a peripheral vasoconstrictor by acting on alpha-adrenergic receptors. It is also an inotropic stimulator of the heart and dilator of coronary arteries as a result of it's activity at the beta-adrenergic receptors.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-13 12:21:49 UTC</pubDate>
         <guid>https://padlet.com/medrozoshantalmarie/8r22guvmt810oo1v/wish/1735839263</guid>
      </item>
   </channel>
</rss>
